Search results
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives $9.33 Consensus Target Price from Analysts
ETF DAILY NEWS· 6 days agoEsperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) has earned an average rating of “Hold” from the five analysts that are currently covering the company& ...
Celanese (CE) Declares Force Majeure Due to Supply Disruptions
Zacks via Yahoo Finance· 7 days agoCelanese (CE) declares force majeure for acetic acid and VAM, expects a 15-20% production impact in...
Applied DNA Sciences, Inc. to Post Q3 2024 Earnings of ($0.64) Per Share, HC Wainwright Forecasts...
ETF DAILY NEWS· 6 days agoApplied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) – Stock analysts at HC Wainwright increased...
PAVmed Inc. (NASDAQ:PAVM) Shares Sold by XML Financial LLC
ETF DAILY NEWS· 7 days agoXML Financial LLC trimmed its holdings in PAVmed Inc. (NASDAQ:PAVM – Free Report) by 93.3% in the fourth quarter, according to its most recent 13F filing with the Securities ...
Traders Purchase Large Volume of Alnylam Pharmaceuticals Call Options (NASDAQ:ALNY)
ETF DAILY NEWS· 18 hours agoAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the recipient of unusually large options trading activity on Monday. In related news, Director Amy W. Schulman ...
Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
GuruFocus.com via Yahoo Finance· 6 days agoOn June 7, 2024, Steven Cohen (Trades, Portfolio)'s firm made a significant addition to its...
Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership
Benzinga· 5 days agoCutting-edge technologies with potential to transform molecular biology Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc.
Stay ADvised: 2024, Issue 11 | JD Supra
JD Supra· 7 days agoA class action lawsuit accuses the makers of Splenda Naturals Stevia, a sugar alternative, of misleading consumers with the claim that the product is "100% Natural." According ...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Down Following Insider Selling
ETF DAILY NEWS· 4 days agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report)’s share price gapped down prior to trading on Thursday following insider...volume of 62,032 shares trading hands ...
3 Top Fertilizer Stocks to Watch From a Promising Industry
Zacks via Yahoo Finance· 7 days agoFavorable demand in major markets for crop nutrients, backed by the strength in global agriculture...